Quantcast

US-HEALTH Summary

Sep 24, 2011, 12:18 a.m.

Food for thought: can fish lower your stroke risk?

NEW YORK (Reuters Health) - People who eat fish a few times each week are slightly less likely to suffer a stroke than those who only eat a little or none at all. That's the conclusion of an analysis of 15 studies, each of which asked people how frequently they ate fish, then followed them for between four and 30 years to see who suffered a stroke.

Kansas firm recalls cantaloupe linked to Listeria outbreak

(Reuters) - A Kansas-based food processor recalled hundreds of pounds of fresh-cut cantaloupe on Friday because of possible Listeria contamination linked to melons from Colorado that were blamed for an outbreak that has killed eight people. Carol's Cuts was recalling 594 pounds of cantaloupe packaged in 5-pound trays and as an ingredient in fruit medleys distributed in Kansas, Missouri and Nebraska, a recall notice posted on the U.S. Food and Drug Administration website said.

Woman wins court order against 1972 Idaho abortion law

SALMON, Idaho (Reuters) - An Idaho woman prosecuted for terminating her own pregnancy with abortion pills she ordered online won a temporary court order on Friday barring enforcement of the decades-old law under which she was charged. But the federal judge in the case also rebuffed her separate bid to block a newly enacted state law that bans abortions after 20 weeks of pregnancy unless there is proof the woman's life is in danger.

Bayer drug a "major new player" in prostate cancer

STOCKHOLM (Reuters) - An experimental drug from Germany's Bayer and Norwegian biotech Algeta that prolongs the lives of patients with advanced prostate cancer is a major step forward in treatment of the disease, cancer experts said on Saturday. A late stage trial of Alpharadin, a new type of drug that delivers minute, highly-charged doses of radiation to secondary tumors in the bone, was halted early after researchers saw patients on the new treatment living almost three months longer on average than those on standard treatment plus placebo.

Group brain tests of athletes not as accurate

NEW YORK (Reuters Health) - Testing young athletes' thinking and memory skills in group settings, as is typically done before every season, may be less accurate than doing the tests individually, a new study finds. Such tests are important because when athletes get head injuries, doctors often compare post-injury scores with preseason ones to see when they are recovered and ready to return to play.

Creepy-crawlies may help heal diabetes wounds

(Reuters Health) - Researchers from Hawaii have a suggestion for how to jump-start the healing of difficult diabetic wounds: let maggots do the work. To allow such wounds to heal, doctors remove infected or dead tissue with scalpels or enzymes, a process they call debridement.

U.S. FDA guidance on biosimilars may be imminent

NEW YORK (Reuters) - The U.S. Food and Drug Administration appears to be on the verge of issuing long-awaiting guidelines for the development of generic versions of complex biotechnology medicines. The FDA still plans to release the guidance by the end of the year but the agency's top drug official, Janet Woodcock, has indicated it could come "as early as the next few weeks, maybe even days," Janice Soreth, deputy director of the agency's Europe office in London, said on Friday.

Editor's Picks

Most Recent